FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreMain Content
ACR Updates Statement About Contrast Material Administration
Feb. 29, 2024
The American College of Radiology® (ACR®) Committee on Drugs and Contrast Media this week released a revised contrast statement that provides flexibility to facilities for contrast studies while maintaining patient safety.
If a physician provides direct supervision for the study — on-site or remotely — the revised statement makes clear a medical professional trained to manage contrast reactions should be on-site.
Healthcare providers with the capabilities specified in the contrast statement can provide the service on-site, as long as those qualifications and the process are consistent with state and local laws and policies, as well as the process and policies of the service site.
Related ACR News
Lower Fee Now in Effect to File No Surprises Act Disputes
Federal agencies released a final rule that updates the No Surprises Act independent dispute resolution process. The rule lowers the IDR administrative or filing fee from $115 to $15.
Read moreACR Urges Funding for NIH All of Us Program
ACR urges Congress to provide dedicated funding for NIH’s All of Us Research Program, a leader in precision medicine technologies and a valuable tool for researchers.
Read more
